Suchergebnisse - "Zhou, Jianying"

PubPharm (142)

21

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy

enthalten in: Cancer communications (London, England) | 2022

von Wu, F. | Jiang, T. | Chen, G. | +37

22

Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy : A Phase 2, Multicenter, Single-Arm, Open-Label Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Lu, S. | Zhang, Y. | Zhang, G. | +52

23

AENEAS : A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Lu, S. | Dong, X. | Jian, H. | +56

CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3103-3105. - PMID 35679530

24

Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

enthalten in: Cancer discovery | 2022

von Wang, M. | Yang, J. | Mitchell, P. | +22

25

Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation : A Phase 1 Dose-Escalation and Dose-Expansion Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Shi, Y. | Zhao, Y. | Yang, S. | +19

26

IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway

enthalten in: American journal of physiology. Cell physiology | 2022

von Ying, L. | Yao, Y. | Lv, H. | +4

27

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer : a Multicenter Phase I/II Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Zhou, Q. | Wu, L. | Hu, P. | +26

28

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC : Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Lu, S. | Wang, Q. | Zhang, G. | +39

CommentIn: Nat Rev Clin Oncol. 2022 Jan;19(1):6. - PMID 34845385

29

Metagenomic sequencing with spiked-in internal control to monitor cellularity and diagnosis of pneumonia

enthalten in: The Journal of infection | 2022

von Zhou, H. | Ouyang, C. | Han, X. | +23

CommentOn: J Infect. 2021 Apr;82(4):22-27. - PMID 33609588

30

Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in the Phase 3 ORIENT-11 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Yang, Y. | Sun, J. | Wang, Z. | +28